21 CFR Part 11 Warning Letters

From the review of the FDA Warning Letters I could not find any observations for pharmaceutical or biotechnology companies directly citing non compliance against 21 CFR Part 11.

21 CFR Part 11 - The next stepFrom the review of the published FDA Warning letters the observations relating to the security and electronic records have not been cited against 21 CFR part 11 however the agency selected